Percheron Therapeutics Limited (ASX:PER)

Percheron Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	10.17	11.87	10.97	19.23	6.02
Cash & Short-Term Investments	10.17	11.87	10.97	19.23	6.02
Cash Growth	-14.32%	8.20%	-42.98%	219.47%	48.31%
Accounts Receivable	0.06	0.08	0.03	0.03	0.01
Other Receivables	1.52	2.48	1.63	1.81	0.59
Receivables	1.58	2.57	1.66	1.84	0.6
Prepaid Expenses	0.65	0.04	0.07	0.61	0.08
Other Current Assets	-	-	-	0.53	-
Total Current Assets	12.4	14.47	12.69	22.22	6.7
Property, Plant & Equipment	0.04	0.06	0.15	0.22	0.3
Total Assets	12.44	14.53	12.84	22.44	7
Accounts Payable	1.43	3.73	1.02	0.33	0.16
Accrued Expenses	0.16	0.25	1.69	0.73	0.8
Current Portion of Leases	0.03	0.04	0.09	0.09	0.08
Other Current Liabilities	0.81	1.14	0	0	0
Total Current Liabilities	2.43	5.15	2.81	1.16	1.05
Long-Term Leases	-	-	0.05	0.13	0.23
Other Long-Term Liabilities	-	0.02	0.01	0	0
Total Liabilities	2.43	5.17	2.87	1.3	1.27
Common Stock	112.05	109.37	98.26	98.13	77.03
Retained Earnings	-103.67	-101.73	-92.29	-80.91	-75.1
Comprehensive Income & Other	1.62	1.72	4	3.92	3.79
Shareholders' Equity	10	9.36	9.98	21.14	5.73
Total Liabilities & Equity	12.44	14.53	12.84	22.44	7
Total Debt	0.03	0.04	0.14	0.23	0.31
Net Cash (Debt)	10.14	11.83	10.83	19.01	5.71
Net Cash Growth	-14.25%	9.25%	-43.04%	232.64%	45.60%
Net Cash Per Share	0.01	0.01	0.02	0.03	0.01
Filing Date Shares Outstanding	1,087	901.54	836.3	668.79	574.48
Total Common Shares Outstanding	1,087	901.54	669.31	668.79	574.48
Working Capital	9.97	9.32	9.88	21.06	5.65
Book Value Per Share	0.01	0.01	0.01	0.03	0.01
Tangible Book Value	10	9.36	9.98	21.14	5.73
Tangible Book Value Per Share	0.01	0.01	0.01	0.03	0.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.